This study provides data for the Russian in vitro diagnostics (IVD) market. Hematology, hemostasis (coagulation), urinalysis, microbiology, clinical chemistry, point of care testing, molecular diagnostics, immunochemistry, and others namely, tissue diagnostics and self-monitoring blood glucose, are the segments discussed in this market. Market revenue has been included in this deliverable. Additional data and analyses are available for urinalysis, hematology, and hemostasis in the US, Western European, and Russian, and Eastern European markets in separate deliverables. There are also separate deliverables looking at Western European, Russian, and Eastern European IVD markets.